Molecular Design

Controlling the behavior of compounds and materials by manipulation of molecular properties.

Friday, 30 November 2018

Ligand efficiency and fragment-to-lead optimizations

›
The third annual survey (F2L2017) of fragment-to-lead (F2L) optimizations was published last week. Given that it was the second survey ...
4 comments:
Sunday, 14 October 2018

A PAINful itch

›
I've been meaning to take a look at the Seven Year Itch (SYI) article on PAINS for some time. SYI looks back over the the preceding 7...
1 comment:
Sunday, 7 October 2018

More hydrogen bonding asymmetries

›
<< Previous I examined an  article on the polarized nature of protein-ligand binding interfaces previously and promised that I...
2 comments:
Sunday, 30 September 2018

Hydrogen bonding asymmetries

›
Next >> Have you ever wondered why the Rule of 5 (Ro5) specifies hydrogen bond (HB) thresholds of 10 acceptors but only 5 donor...
2 comments:
Thursday, 13 September 2018

On the Nature of QSAR

›
With EuroQSAR2018 fast approaching, I'll share some thoughts from Brazil since I won't be there in person. I've not got any QS...
Saturday, 7 April 2018

Hammett

›
I first became aware of Louis Hammett  during the third term of my first year as an undergraduate at the University of Reading. Hammett was...
Sunday, 1 April 2018

The maximal quality of molecular interactions

›
<< previous || next >> There is a lot more to drug design than maximization of affinity and the key to successful design is a...
3 comments:
‹
›
Home
View web version

Contributors

  • Mel
  • Peter Kenny
Powered by Blogger.